Evotec SE(EVO) - 2022 Q4 - Earnings Call Transcript

Operator Ladies and gentlemen, with this, the conference has now concluded and you may disconnect your telephone. Thank you for joining and have a pleasant day. Goodbye. So, specifically what people say no to, I think people, the data should tell that. We are in the process because value proposition is attractive in a world of IRA, cost constraint, in a world of providing access to biologics. This is an important proposition. And in short, we have maybe some partners who are not attractive to that, but whoe ...